1. Home
  2. MDWD vs HMST Comparison

MDWD vs HMST Comparison

Compare MDWD & HMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • HMST
  • Stock Information
  • Founded
  • MDWD 2000
  • HMST 1921
  • Country
  • MDWD Israel
  • HMST United States
  • Employees
  • MDWD N/A
  • HMST N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • HMST Major Banks
  • Sector
  • MDWD Health Care
  • HMST Finance
  • Exchange
  • MDWD Nasdaq
  • HMST Nasdaq
  • Market Cap
  • MDWD 184.8M
  • HMST 191.6M
  • IPO Year
  • MDWD 2014
  • HMST 2012
  • Fundamental
  • Price
  • MDWD $17.64
  • HMST $10.84
  • Analyst Decision
  • MDWD Strong Buy
  • HMST Buy
  • Analyst Count
  • MDWD 1
  • HMST 2
  • Target Price
  • MDWD $25.00
  • HMST $14.75
  • AVG Volume (30 Days)
  • MDWD 68.1K
  • HMST 195.1K
  • Earning Date
  • MDWD 11-26-2024
  • HMST 01-27-2025
  • Dividend Yield
  • MDWD N/A
  • HMST N/A
  • EPS Growth
  • MDWD N/A
  • HMST N/A
  • EPS
  • MDWD N/A
  • HMST N/A
  • Revenue
  • MDWD $19,720,000.00
  • HMST $169,710,000.00
  • Revenue This Year
  • MDWD $10.37
  • HMST N/A
  • Revenue Next Year
  • MDWD $26.36
  • HMST $17.03
  • P/E Ratio
  • MDWD N/A
  • HMST N/A
  • Revenue Growth
  • MDWD N/A
  • HMST N/A
  • 52 Week Low
  • MDWD $11.04
  • HMST $8.09
  • 52 Week High
  • MDWD $24.00
  • HMST $16.10
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 49.76
  • HMST 49.99
  • Support Level
  • MDWD $15.80
  • HMST $9.36
  • Resistance Level
  • MDWD $19.60
  • HMST $11.99
  • Average True Range (ATR)
  • MDWD 0.98
  • HMST 0.57
  • MACD
  • MDWD 0.06
  • HMST 0.05
  • Stochastic Oscillator
  • MDWD 48.42
  • HMST 53.24

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About HMST HomeStreet Inc.

HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.

Share on Social Networks: